WINTON GROUP Ltd Has $29.25 Million Stock Holdings in CME Group Inc. $CME

Key Points

• WINTON GROUP Ltd more than doubled its CME Group stake by 120.7% in the second quarter, owning 132,440 shares valued at approximately $29.25 million. Institutional investors collectively hold 87.75% of CME’s stock.
• Analyst sentiment is mixed: CME has an overall “Hold” rating, with an average price target of $289.75, as ratings range from “Sell” to “Outperform.”
• CME exceeded quarterly expectations with $2.99 in adjusted EPS and $1.71 billion in revenue, while declaring a $1.30 quarterly dividend, equal to a 1.9% annualized yield.

WINTON GROUP Ltd increased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 120.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 132,440 shares of the financial services provider's stock after acquiring an additional 72,440 shares during the quarter. CME Group comprises 0.9% of WINTON GROUP Ltd's portfolio, making the stock its 10th biggest holding. WINTON GROUP Ltd's holdings in CME Group were worth $29,247,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Bridgewater Advisors Inc. acquired a new position in CME Group in the 2nd quarter valued at $612,000. The Manufacturers Life Insurance Company acquired a new stake in shares of CME Group during the second quarter worth $53,671,000. FLC Capital Advisors bought a new stake in shares of CME Group in the fourth quarter valued at about $2,122,000. Haverford Trust Co bought a new stake in shares of CME Group in the second quarter valued at about $13,818,000. Finally, Bowie Capital Management LLC acquired a new position in shares of CME Group in the second quarter valued at about $22,991,000. Institutional investors own 87.75% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CME. Bank of America lifted their price objective on shares of CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a research note on Thursday, July 23rd. Raymond James Financial reaffirmed an "outperform" rating and set a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. Piper Sandler dropped their price target on shares of CME Group from $329.00 to $295.00 and set an "overweight" rating for the company in a research report on Wednesday, July 15th. The Goldman Sachs Group cut their price target on CME Group from $267.00 to $245.00 and set a "sell" rating for the company in a research note on Tuesday, June 30th. Finally, Erste Group Bank downgraded CME Group from a "buy" rating to a "hold" rating in a research report on Friday, June 5th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $289.75.

CME Group Trading Down 1.3%

Shares of CME Group stock opened at $274.70 on Thursday. The firm's 50-day moving average price is $262.03 and its two-hundred day moving average price is $277.67. The company has a market capitalization of $98.78 billion, a price-to-earnings ratio of 23.30, a PEG ratio of 3.29 and a beta of 0.24. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company's revenue was up .8% on a year-over-year basis. During the same period in the previous year, the business earned $2.96 earnings per share. On average, analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group's dividend payout ratio is currently 44.11%.

Insider Buying and Selling at CME Group

In other CME Group news, Director William Shepard acquired 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company's stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.30% of the stock is currently owned by corporate insiders.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Shareholder distribution: CME is scheduled to distribute approximately $467 million in dividends on September 25, reinforcing its appeal to income-oriented investors and highlighting the exchange operator’s strong cash-generation profile. CME Group's $467 Million Dividend: What Shareholders Collect Sept. 25
• Positive Sentiment: Product expansion: CME’s new single-stock futures offer investors leveraged and capital-efficient exposure to individual equities. The product broadens CME’s equity derivatives lineup and could create additional trading volume and fee revenue over time. CME's New Single Stock Futures: What Are The Advantages Vs. Stocks?
• Positive Sentiment: European market entry: CME plans to enter the European dairy market through a deal involving EEX, expanding its addressable market and potentially improving its international commodities presence. CME Group to enter European dairy market through EEX deal
• Neutral Sentiment: Leadership succession: CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. The planned internal transition may provide continuity, although investors could monitor execution during the leadership change. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Interest-rate backdrop: Reports that Federal Reserve Chair Warsh favors rate hikes, while the Treasury considers buying longer-maturity debt, point to continued uncertainty over rates, inflation and bond-market conditions. These factors can affect CME’s interest-rate and fixed-income trading volumes. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation: The Hyperliquid Policy Center filed an amicus brief urging dismissal of CME’s lawsuit against the CFTC. The development adds uncertainty to CME’s regulatory position and could weigh on sentiment surrounding its digital-asset and derivatives initiatives. Hyperliquid Policy Center Files Amicus Brief Urging Dismissal of CME’s Suit Against CFTC

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company's principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.